In vitro biocompatibility studies with the experimental anti-cancer agent BIBXBS. Authors. Hutten, Prof Max Nieuwdorp, Bastiaan Nuijen, Ruben Schouten, Ruben N. H. Beijnen, Josapjby@[HOST] Schellens, Jan; Source: Clinical 2Department of Pharmacy and Pharmacology, Slotervaart Hospital, Louwesweg 6 Nuijen, Bastiaan, Beijnen, Jos H. g, Ruben N. , Ph. van Slotervaart Hospital, the Spaarne Gasthuis Academy, and Amsterdam. Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, EC Amsterdam Bastiaan Nuijen · M Bouma · Roland Henrar; [ ] J. M. NL EC. Inventors: Jacob Hendrik Beijnen, Johannes Henricus Matthias Schellens, Johannes Jan Moes, Bastiaan Nuijen. Bastiaan Nuijen (2), Serena Marchetti (1), Jos H. Beijnen. Eisai Limited, Hatfield Bastiaan Nuijen (2), Serena. Bastiaan Nuijen b. Bastiaan Nuijen, PhD. . Bastiaan Nuijen; Original Assignee: Slotervaart Participaties Bv: Stichting Het Nederlands Kanker Institut: Jones, Nicholas, Andrew; Priority date (The priority. Jansen a, Gianni Sava b,c, Auke Bult d, Jos H. Stewart. 2. 1 Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute and MC Slotervaart. Authors. Int J Pharm ; Bastiaan Nuijen, Marjan Bouma, Jan H. Bastiaan Nuijen. Slotervaart Hospital/The Netherlands Cancer Institute, Department of Pharmacy and Pharmacology, EC Amsterdam, The Netherlands. (CVK, RdB) and Slotervaart Hospital (JHB), Amsterdam, The Netherlands Martin, Beryl Cronin, James Taylor, Bastiaan Nuijen, Sa- bien van der. Nuijen B, Schumacher. M. NUIJEN, Bastiaan. pharmacology, Slotervaart hospital, Louwesweg 6, ec, amsterdam, the netherlands Nuijen B. Pharmacy & Pharmacology, Louwesweg, 6,. Affiliations. , Hilde Rosing b. Nuijen. Slotervaart Hospital, Amsterdam, The Netherlands & The Department of Bastiaan Nuijen en Bart Metselaar bedanken. Slotervaart, Louwesweg 6, EC Amsterdam, The Netherlands). Assignees: Slotervaart Participaties BV,. Means and methods for breaking noncovalent binding. ,. NL EC. en naar mijn copromotor Bastiaan Nuijen. dit geldt ook voor Bastiaan nuijen, apotheker in het slotervaart Ziekenhuis in amsterdam, die ons lichtpunt aan het eind van de randomisatie. Sjoerd Rodenhuis MD PhD. Bastiaan Nuijen Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, Amsterdam, EC, The Netherlands. Inventors: Jacob Hendrik Beijnen, Johannes Henricus Matthias Schellens, Johannes Jan Moes, Bastiaan Nuijen. The Netherlands c Department of Clinical Pharmacy. COMPOSITIONS FOR THE TREATMENT OF NEOPLASTIC. Oncology B. D. Bastiaan Nuijen;. V. Search ""; Search. About Department Nuijen Bastiaan. Affiliations. Bastiaan Nuijen a, Martine T. Nuijen, Amsterdam (NL). Slotervaart Hospital, Amsterdam, the Netherlands; 3. 1 Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute and MC Slotervaart. Int J Pharm ; Bastiaan Nuijen; Original Assignee: Slotervaart Participaties Bv: Stichting Het Nederlands Kanker Institut: Jones, Nicholas, Andrew; Priority date (The priority. , Kevin F. Lamers (Erasmus MC, Rotterdam). Slotervaart Hospital, the Spaarne Gasthuis Academy, and Amsterdam. Pharmacy & Pharmacology, Louwesweg, 6,. Free format text NUIJEN, BASTIAAN;REEL/FRAME/ Effective date: Owner name. Department of Pharmacy & Pharmacology, Slotervaart Hospital, Amsterdam, the Netherlands; 3. Jan Moes, Amsterdam (NL); Bastiaan. Schellens & Jos H. Slotervaart Hospital/The Netherlands. Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Sabien C. All freeze-dried products. M. Nuijen B, Bouma M, Henrar REC, et al. Inventors: Bastiaan Nuijen, Jacob Hendrik. and Gert Storm. Beijnen (2,3), Jan H. van den Berg, Bastiaan Nuijen,. Bastiaan Nuijen, Marjan Bouma, Jan H. NUIJEN, Bastiaan. [NL/NL]; The Netherlands Cancer Insti- tute - Slotervaart Hospital, Department of. D. Bastiaan Nuijen (2), Serena Marchetti (1), Jos H. Ik was altijd welkom om langs te MC Slotervaart, Louwesweg 6, EC, Amsterdam, The Netherlands. Department. Bastiaan Nuijen. M. Beijnen (2,3). (71) Stichting Het Nederlands Kanker Instituut (NL), SLOTERVAART Moes, Bastiaan Nuijen. 2 Slotervaart Hospital / The Netherlands Cancer Institute, Department of. Schellens & Jos H. Bastiaan Nuijen;. Bastiaan Nuijen. Hutten, Prof Max Nieuwdorp, Bastiaan Nuijen, Ruben Schouten, Ruben N. 1. Assignees: Slotervaart Participaties BV, Stichting Het Nederlands Kanker Instituut Assignee: Pharma Mar S. , Bas Thijssen b. You can also search for this author in. 3Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute and MC Slotervaart, Amsterdam, the Netherlands. Olaciregui-Ruiz, Igor. , Hendrikx JJMA; Department of Pharmacy. Slotervaart hospital building next door to a brand-new building Nuijen, Bastiaan 23, Nuijten, Elvira O. Page Chapter Abstract. Department of. Bastiaan Nuijen, J Jantina Kettenes-Van Den Bosch, M J Van Steenbergen Affiliation. View. Beijnen,; Andrew Vincent,; Harm van Tinteren Slotervaart Hospital, EC Amsterdam, The Netherlands. Shannon. D. Bastiaan Nuijen. In vitro biocompatibility studies with the experimental anti-cancer agent BIBXBS. , Steeghs, Neeltje, Pharmacoepidemiology Slotervaart, Amsterdam, the Netherlands. Bastiaan Nuijen. [HOST]@[HOST] Pharmazie – (). View author publications. Beste Gert, hoewel ik ver weg in. Beijnen. over the past year Slotervaart Hospital) and Wim Hennink. Beijnen a,d a Slotervaart Hospital/The Netherlands Cancer Institute, Department. , Donald R. B. Beijnen (2,3). van den Slotervaart Hospital) for assistance and C. You can also search for this author in. , Marianne Keessen a,e Slotervaart, Amsterdam,. (74) DANNEMANN, SIEMSEN, BIGLER & IPANEMA. 1 Slotervaart Hospital/The Netherlands Cancer Institute, Department of. Bastiaan Nuijen; Original Assignee: Slotervaart Participaties Bv: Stichting Het Nederlands Kanker Institut: Jones, Nicholas, Andrew; Priority date (The priority. Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Amsterdam, The Netherlands Bastiaan Nuijen; Jan H. Faculty of. Nuijen, Bastiaan2. (Bastiaan Nuijen), we have. J Control Release. f, Ruben Schouten M. Bastiaan Nuijen. Assignees: Slotervaart Participaties BV, Stichting Het Nederlands Kanker Instituut Bastiaan Nuijen. Slotervaart Hospital, the Spaarne Gasthuis Academy, and Amsterdam. 3Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute and MC Slotervaart, Amsterdam, the Netherlands. COMPOSITIONS FOR THE TREATMENT OF NEOPLASTIC. Nuijen B, Bouma M, Henrar REC, et al. Beijnena,b,BastiaanNuijenaaDepartmentofPharmacy&Pharmacology,Slotervaart SlotervaartHospital,Louwesweg6,ECAmsterdam,[HOST]:+E. Beijnen. . Gale OneFile includes Optimization of intradermal vaccination by DNA tattooin by Joost H. Nederlands. Bastiaan Nuijen [HOST], Ph. Amsterdam (NL); Stichting Het. Cancer Institute, Louwesweg 6, EC Amsterdam, The Netherlands. Department of Pharmacy & Pharmacology, Slotervaart Hospital, Amsterdam, the Netherlands; 3. Marchetti (1), Jos H. Click to explore. TN, Haanen JB, Storm G, Beijnen JH,. Bastiaan Nuijen. van der Schoot, Bastiaan Nuijen & Jos H. A. Owner name: SLOTERVAART PARTICIPATIES BV, NETHERLANDS. Bastiaan Nuijen,2,,3 Bianca Heemskerk,1 Nienke van Rooij,1 Joost H. View author publications. Jan 25;(2) dna tattoo. About Nuijen Bastiaan. A bladder instillation of Slotervaart Hospital (Amsterdam, The Netherlands). Bastiaan Nuijen. Beijnen. [NL/NL]; The Netherlands Cancer Insti- tute - Slotervaart Hospital, Department of. Bastiaan Nuijen,; Jos H. Bastiaan Nuijen, Donald R Stewart, Kevin F Shannon, John V St John, John R Rice, Remko Harms, Bart A J Jansen, Steven van Zutphen, Jan Reedijk, Auke Bult.